Experimental studies have examined how activation of GHS-R1a influences growth hormone physiology, insulin-like growth factor-1 (IGF-1) signaling, metabolic regulation, and cellular adaptation processes
In clinical trials, 6-16% of participants discontinued retatrutide due to gastrointestinal adverse events (Jastreboff et al., NEJM, 2023)
Because they contain the exact same active ingredient ( Semaglutide ), many patients refer to the oral tablets as Wegovy Pills. Both forms work by mimicking the GLP-1 hormone to curb appetite, regulate blood sugar, and slow gastric emptying
Hypoglycemia: While GLP-1 medications themselves rarely cause hypoglycemia (low blood sugar) when used as monotherapy, combining them with a mechanism of action that causes hypoglycemia such as insulin or sulfonylureas can increase the risk of hypoglycemia
The gradual dose titration recommended in prescribing guidance aims to minimise gastrointestinal side effects by allowing the body time to adapt to the medication's effects on gut motility